354
Views
3
CrossRef citations to date
0
Altmetric
Original Article

The plurality of payers’ perspectives on hematopoietic stem cell transplantation

&
Pages s202-s207 | Published online: 12 Nov 2013

References

  • Pasquini MC, Wang Z. Current use and outcome of hematopoietic stem cell transplantation: CIBMTR Summary Slides. Available at: http://www.cibmtr.org (accessed 4 January 2012).
  • Hahn T, McCarthy PL, Hassebroek A, Klein J, Rizzo JD, Parsons SK, et al.. Significant improvement in day 100 and 1-year overall survival in patients who underwent myeloablative allogeneic hematopoietic cell transplant in the US or Canada between 1994 and 2005.Blood. 2010;116:3509 (abstract).
  • Gooley TA, Chien JW, Pergam SA, Hingorani S, Sorror ML, Boeckh M, et al.. Reduced mortality after allogeneic hematopoietic-cell transplantation.N Engl J Med.2010; 363: 2091–101.
  • Barr RD, Feeny D, Furlong W. Economic evaluation of treatments for cancer in childhood.Eur J Cancer.2004; 40: 1335–45.
  • Schulman KA, Yabroff KR. Measuring the cost-effectiveness of cancer care.Oncology.1995; 9: 523–30, 3.
  • Wong YN, Hamilton O, Egleston B, Salador K, Murphy C, Meropol NJ. Understanding how out-of-pocket expenses, treatment value, and patient characteristics influence treatment choices.Oncologist.2010; 15: 566–76.
  • Barr RD, Sala A. Hidden financial costs in the treatment for childhood cancer.J Pediatr Hematol Oncol.2003; 25: 842–4.
  • American Hospital Association. Hospitals continue to feel lingering effects of the economic recession. Available at: http://www.aha.org/presscenter/pressrel/2010/100623-pr-recessionimpact.shtml (accessed 5 January 2012).
  • Majhail NS, Mothukuri JM, Brunstein CG, Weisdorf DJ. Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of post-transplant complications.Biol Blood Marrow Transplant.2009; 15: 564–73.
  • Majhail NS, Mothukuri JM, MacMillan ML, Verneris MR, Orchard PJ, Wagner JE, et al.. Costs of pediatric allogeneic hematopoietic-cell transplantation.Pediatr Blood Cancer.2010; 54: 138–43.
  • Parsons SK, Weidner RA, Guinan EC. Implications of global pricing in pediatric stem cell transplantation: risk minimization strategies.Biol Blood Marrow Transplant. 2001; 7: 84 (abstract).
  • Schulman KA, Birch R, Zhen B, Pania N, Weaver CH. Effect of CD34+ cell dose on resourse utilization in patients after high-dose chemotherapy with peripheral-blood stem-cell support.J Clin Oncol.1999; 17: 1227–33.
  • Cordonnier C, Maury S, Esperou H, Pautas C, Beaune J, Rodet M, et al.. Do minitransplants have minicosts? A cost comparison between myeloablative and nonmyeloablative allogeneic stem cell transplant in patients with acute myeloid leukemia.Bone Marrow Transplant.2005; 36: 649–54.
  • Farah RA, Aquino VM, Munoz LL, Sandler ES. Safety and cost-effectiveness of outpatient total body irradiation in pediatric patients undergoing stem cell transplantation.J Pediatr Hematol Oncol.1998; 20: 319–21.
  • Applegate GL, Mittal BB, Kletzel M, Morgan E, Johnson P, Danner K, et al.. Outpatient total body irradiation prior to bone marrow transplantation in pediatric patients: a feasibility analysis.Bone Marrow Transplant.1998; 21: 651–2.
  • Peters WP, Ross M, Vredenburg JJ, Hussein A, Rubin P, Dukelow K, et al.. The use of intensive clinic support to permit outpatient autologous bone marrow transplantation for breast cancer.Semin Oncol. 1994; 4Suppl 7: 25–31.
  • Rizzo JD, Vogelsang GB, Krumm S, Frink B, Mock V, Bass EB. Outpatient-based bone marrow transplantation for hematologic malignancies: Cost saving or cost shifting?J Clin Oncol.1999; 17: 2811–8.
  • Kim P. Cost of cancer care: the patient perspective.J Clin Oncol.2007; 25: 228–32.
  • Cohn RJ, Goodenough B, Foreman T, Suneson J. Hidden financial costs in treatment for childhood cancer: an Australian study of lifestyle implications for families absorbing out-of-pocket expenses.J Pediatr Hematol Oncol.2003; 25: 854–63.
  • Meehan KR, Fitzmaurice T, Root L, Kimtis E, Patchett L, Hill J. The financial requirements and time commitments of caregivers for autologous stem cell transplant recipients.J Support Oncol.2006; 4: 187–90.
  • Goossens ME, Molken Rutten-vanMP, Vlaeyen JW, van der Linden SM. The cost diary: a method to measure direct and indirect costs in cost-effectiveness research.J Clin Epidemiol.2000; 53: 688–95.
  • Lauzier S, Maunsell E, Drolet M, Coyle D, Hebert-Croteau N. Validity of information obtained from a method for estimating cancer costs from the perspective of patients and caregivers.Qual Life Res.2010; 19: 177–89.
  • Dicker M, Sunshine JH. Determinants of financially burdensome family health expenses: United States, 1980. Hyattsville (MD): US Department of Health and Human Services, Public Health Service, National Center for Health Statistics; 1988. p. 1–66.
  • Grumbach K, Bodenheimer T. Mechanisms for controlling costs.JAMA.1995; 273: 1223–30.
  • Bernard D, Banthin J. Family level expenditures on health care and insurance premiums among the nonelderly population, 2006. Rockville, MD: Agency for Healthcare Research and Quality; 2009. Report No. Research Findings No. 29.
  • Newacheck PW, Inkelas M, Kim SE. Health services use and health care expenditures for children with disabilities.Pediatrics.2004; 114: 79–85.
  • Limburg H, Shaw AK, McBride ML. Impact of childhood cancer on parental employment and sources of income: a Canadian pilot study.Pediatr Blood Cancer.2008; 51: 93–8.
  • Miedema B, Easley J, Fortin P, Hamilton R, Mathews M. The economic impact on families when a child is diagnosed with cancer.Curr Oncol.2008; 15: 173–8.
  • Lerner D, Amick BC, III, Rogers WH, Malspeis S, Bungay K, Cynn D. The work limitations questionnaire.Med Care.2001; 39: 72–85.
  • Burton WN, Chen CY, Conti DJ, Pransky G, Edington DW. Caregiving for ill dependents and its association with employee health risks and productivity.J Occup Environ Med.2004; 46: 1048–56.
  • Parsons S, Terrin N, Ratichek S, Tighiouart H, Recklitis CJ, Chang G. Trajectories of HRQL following pediatric hematopoietic stem cell transplantation (HSCT). QLR J. 2009;A–44:Abstract1420.
  • Parsons SK, Barlow SE, Levy SL, Supran SE, Kaplan SH. Health-related quality of life in pediatric bone marrow transplant survivors: according to whom?Int J Cancer Suppl.1999; 12: 46–51.
  • Parsons SK, Shih MC, Mayer DK, Barlow SE, Supran SE, Levy SL, et al.. Preliminary psychometric evaluation of the Child Health Ratings Inventories (CHRIs) and Disease-Specific Impairment Inventory-HSCT (DSII-HSCT) in parents and children.Qual Life Res.2005; 14: 1613–25.
  • Parsons SK, Shih MC, DuHamel KN, Ostroff J, Mayer DK, Austin J, et al.. Maternal perspectives on children’s health-related quality of life during the first year after pediatric hematopoietic stem cell transplant.J Pediatr Psychol.2006; 31: 1100–15.
  • Kelly MJ, Pennarola BW, Rodday AM, Parson SK, on behalf of the Journeys to Recovery Study and the HSCT-CHESS Study. Health-related quality of life (HRQL) in children with sickle cell disease and thalassemia following hematopoietic stem cell transplant (HSCT). Pediatr Blood Cancer. 2011 Dec 19.
  • US Department of Health and Human Services HRaSAMaCHB. Families of CSHCN have adequate private and/or public insurance to pay for the services they need. The National Survey of Children with Special Health Care Needs Chartbook 2005–2006. Rockville (MD): US Department of Health and Human Services; 2008.
  • McCubbin H, Patterson J, Wilson L. Family inventory of life events and changes (FILE, 1983). In: McCubbin H, Thompson A, editors. Family assessment inventories for research and practice. Madison (WI): University of Wisconsin-Madison; 1991. p. 81–98.
  • Leske JS, Jiricka MK. Impact of family demands and family strengths and capabilities on family well-being and adaptation after critical injury.Am J Crit Care.1998; 7: 383–92.
  • Starzomski R, Hilton A. Patient and family adjustment to kidney transplantation with and without an interim period of dialysis.Nephrol Nurs J.2000; 27: 17–821–32.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.